Clinical Trial Update: VISUPRIME® Eye Drops [NA]

View source ↗

Summary

Clinical trial update noting the completion of a VISUPRIME Eye Drops study sponsored by VISUfarma SpA for several retinal diseases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Diabetic Macular Edema
• Macular Edema
• Myopic Choroidal Neovascularization
• Proliferative Diabetic Retinopathy

Drugs mentioned

• VISUPRIME Eye Drops

Snippet

Sponsor: VISUfarma SpA | Conditions: Macular Degeneration, Age Related, Myopic Choroidal Neovascularisation | NA | Status: COMPLETED